MedTrace Logo

Investigating and Characterizing the Immune Response to Prostate Cancer

NCT03331367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2020-08-07

No results posted yet for this study

Summary

This study is a clinical study to investigate and characterize the immune response profile to four different prostate cancer treatments (total cryotherapy, focal cryotherapy, Cyberknife SBRT, and radical prostatectomy) in patients with localized prostate cancer.

Conditions

Interventions

PROCEDURE

Blood draw

Patients in all four study arms will provide a blood sample to evaluate the immune response to prostate cancer treatment.

PROCEDURE

Urine sample

Patients in all four study arms will provide a urine sample to evaluate the immune response to prostate cancer treatment.

Sponsors & Collaborators

Principal Investigators

  • Aaron E Katz, MD · NYU

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-14
Primary Completion
2020-02-25
Completion
2020-02-25

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03331367 on ClinicalTrials.gov